Bafna Pharmaceuticals launches RARICAP injection in domestic market

Bafna Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532989 | NSE: BAFNAPH

20 Nov 2013 Evaluate

Bafna Pharmaceuticals, a Chennai-based Pharma company, has launched RARICAP in injection form as RARICAP S in domestic market. This is another product in women wellness segment for Iron Deficiency Anaemia during Pregnancy and also for Anaemia in Chronic Kidney Disease.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Peers

Company Name	CMP
Sun Pharma. Inds.	1850.25
Dr. Reddys Labs.	1200.45
Cipla	1403.85
Lupin	2087.80
Zydus Lifesciences	1192.80
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.